SOURCE: GrowBLOX Sciences, Inc.

GrowBLOX Sciences, Inc.

September 11, 2014 09:21 ET

UPDATE - Growblox Sciences, Inc. (OTCQB: GBLX) Featured in Huffington Post Article

"Biotechnology's Response to the Burgeoning Medical-Marijuana Industry"

LAS VEGAS, NV--(Marketwired - Sep 11, 2014) -   Growblox Sciences, Inc. (OTCQB: GBLX) a leader in natural, and medicinal-grade cannabis and cannabis concentrates announced today that the company was featured on Huffington Post Article. The piece focuses on Dr. Small-Howard whom is helping commercialize and productize medical marijuana using a proprietary methodology that uses genetic cultures to produce a scientifically consistent result. GB Sciences has several trademarked GrowBLOX™ technologies, including the InCUBEator Cannabis Propagation Chamber, GrowBLOX™ Cannabis Grow Chambers, CureBLOX Cannabis Drying System, and ConversionLAB Cannabis Extraction Solutions.

Link: Huffington Post Article

The company's feature in the Huffington Post reviews the following:

  • Marijuana can be grown legally in 23 states and the District of Columbia; and another 11 states have limited legal access, often for research purposes, according to the National Conference of State Legislatures.
  • GB Sciences has several trademarked GrowBLOX™ technologies, including the InCUBEator Cannabis Propagation Chamber, GrowBLOX™ Cannabis Grow Chambers, CureBLOX Cannabis Drying System, and ConversionLAB Cannabis Extraction Solutions.
  • GB Sciences, Inc.'s proprietary methods can yield up to five harvests a year, outpacing industry competition, according to the firm.
  • GB Sciences is currently working to further their research in various therapy areas and is equally excited to explore the possibility of using other molecules from plant extracts to further enhance the medical properties of cannabinoids.

About GrowBLOX Sciences, Inc.: GrowBLOX Sciences, Inc. (OTCQB: GBLX), is a medical cannabis research and development company whose product line consists of a series of solutions for the commercialization of medical- grade cannabis. All products are consistently manufactured with clinical, laboratory precision. The company is headquartered in Las Vegas, NV and has subsidiaries in Florida, Chicago, and Puerto Rico.

About Forward-Looking Statements:

This Press Release may contain certain forward-looking statements within the meaning of the Securities Litigation Reform Act of 1995. Growblox Sciences, Inc. has tried, whenever possible, to identify these forward-looking statements using words such as "anticipates," "believes," "estimates," "expects," "plans," "intends," "potential" and similar expressions. These statements reflect Growblox Sciences, Inc. current beliefs and are based on information currently available to it. Accordingly, such forward-looking statements involve known and unknown risks, uncertainties and other factors which could cause Growblox Sciences, Inc. actual results, performance or achievements to differ materially from those expressed in or implied by such statements. Growblox Sciences, Inc. undertakes no obligation to update or provide advice in the event of any change, addition or alteration to the information contained in this Press Release including such forward-looking statements.

*PR and Editorial Services by 1800PublicRelations.com

Contact Information